A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Additionally, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Professionals Express Concerns
However, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.
Some experts stated the popularity for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.
Legal Position and Enforcement
Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Reaction and Content Removal
According to TikTok, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in enhancing compliance measures.
Digital Marketplace Operations
Investigations also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, filled with photos of weight loss, positive reviews and step-by-step guides for preparing or administering at home.
Within minutes of joining one group, a vendor shared WhatsApp details, where most purchases take place. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.
Product Details and Costs
Within these communities, posts show black plastic packages with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors usually sold at £160 for 20 milligrams. When questioned how much time a injector should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram said it regularly moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering substances they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are extremely risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.
Her staff has already encountered patients harmed by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject patients to potentially serious health risks”.
